caret

Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

19 Sep 2023

CEPI and Bio Farma partnership boosts rapid response vaccine manufacturing for the Global South
Bio Farma to establish cutting-edge mRNA and viral vector rapid response vaccine manufacturing capability with CEPI support and investment of up to $15 million.

Read more

Read article

18 Sep 2023

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
CEPI commits funding of up to $90 million for the development of mRNA-based vaccine candidates

Read more

14 Sep 2023

CEPI partners with University of California, Davis to advance a vaccine against potentially deadly Rift Valley fever virus into clinical trials
CEPI to invest $28.5 million, with support from the EU, in UC Davis-led clinical trials of a Rift Valley fever (RVF) vaccine in Tanzania, a country at high-risk of outbreaks of the disease.

Read more

01 Sep 2023

CEPI and IVI renew partnership to accelerate development of vaccines against emerging infectious disease threats
IVI will provide technical services for CEPI-funded projects, leveraging IVI’s expertise and capabilities

Read more

29 Aug 2023

Partnering to deliver the 100 Days Mission
Explore CEPI's dynamic partnerships for global pandemic readiness. Uniting equity and innovation, our collaborations drive rapid pandemic response. See how we're boosting preparedness with agile partnerships like the University of Oxford.

Read more

29 Aug 2023

CEPI and University of Oxford to accelerate vaccine development against Disease X 
CEPI pledges $80 million to support development of vaccines against outbreak threats, partnering with the University of Oxford to harness their expertise for rapid pandemic response through adaptable ChAdOx technology

Read more

23 Aug 2023

Clinical trials in remote rainforests: how vital Ebola research in DRC enhances local expertise and infrastructure
Prof. Hypolite Muhindo-Mavoko talks about the challenges and rewards that come with conducting vaccine trials for deadly viruses in the isolated city of Boende

Read more

08 Aug 2023

CEPI to support development of self-amplifying mRNA vaccine technology for use against Disease X
CEPI to provide funding of up to US$3.6 million, which will support optimisation of the technology platform to enhance immunogenicity.

Read more

Read article

18 Jul 2023

Using AI to speed up vaccine development against Disease X
CEPI partners with Houston Medical Research Institute to use artificial intelligence for design of vaccines to fight diseases with pandemic potential

Read more

05 Jul 2023

What are monoclonal antibodies, and what role could they play in ending a potential pandemic?
Monoclonal antibodies could play an important complementary role, alongside vaccines, in helping to end future epidemic and pandemic threats.

Read more

27 Jun 2023

CEPI partners with RVAC Medicines to accelerate manufacturing of mRNA vaccines
Funding of up to US$3 million aims to accelerate the manufacturing process for RVAC's mRNA vaccine platform technology

Read more

©2023 CEPI. All rights reserved